Teva launches cash and shares bid for Mylan
Teva Pharmaceuticals has announced a cash and shares bid for US rival Mylan at $82 per share.
Mylan Inc.
$0.00
19:30 08/12/22
0.00%
$0.00
Nasdaq 100
20,394.13
12:15 15/11/24
-2.40%
-502.54
--More to follow--